Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 2084 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 2127 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 2442 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 2560 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 2980 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 3065 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 3124 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 3619 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4075 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4235 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4371 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4413 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4475 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4611 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4640 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4657 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 4788 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5297 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5329 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5378 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5484 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5646 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5675 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5780 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5898 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 5991 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6008 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6051 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6055 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6347 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6620 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6703 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6820 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 6971 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7020 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7031 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7152 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7482 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7548 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7552 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7569 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7637 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7685 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7697 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 7748 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8035 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8108 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8125 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8162 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8408 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8472 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8688 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8698 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 8882 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9077 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9292 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9483 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9706 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9830 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9904 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9917 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9921 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9922 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 9966 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10023 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10051 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10238 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10327 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10356 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10413 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10444 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10654 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10691 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10824 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 10838 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11131 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11158 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11168 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11379 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11398 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11440 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11544 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11685 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11726 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11854 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11895 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 11999 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12069 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12646 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12667 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12723 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12737 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 12981 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13007 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13151 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13320 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13583 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13638 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13707 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13863 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13967 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13984 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 13995 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14056 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14182 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14274 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14380 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14407 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14627 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14668 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 14912 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 15300 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 15469 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 15712 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 15843 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 15904 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16477 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16546 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16571 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16617 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16676 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16733 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 16986 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 17255 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 17268 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 17465 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 17764 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 18513 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 18743 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 18934 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 19375 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 19521 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 20461 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 20471 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 20509 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 20535 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 22050 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 22478 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 22795 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 23424 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 23596 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 24001 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 24958 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 27303 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 27698 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 28107 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 28266 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 28898 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 29212 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 30623 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | 36456 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | Normal Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | No | PAH | Male | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | Normal Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | THYMIDINE (M+CL)- | Peak area normalized | Yes | PAH | Female | Cath |